Zoledronic acid - Open Access .click

Results 241 to 250 of about 5,138,607 (284)

Some of the next articles are maybe not open access.

Zoledronic acid‐induced oxidative damage and endoplasmic reticulum stress‐mediated apoptosis in human embryonic kidney (HEK‐293) cells

Journal of biochemical and molecular toxicology, 2022
Zoledronic acid, a nitrogen‐containing bisphosphonate drug, is used for the treatment of osteoporosis, Paget's disease of bone, and tumor‐induced osteolysis.
M. Kara +5 more
semanticscholar +1 more source

Zoledronic Acid

Drugs, 2001
Zoledronic acid (zoledronate) is a new generation bisphosphonate that inhibits osteoclast bone resorption. It was much more potent than other bisphosphonates at inhibiting 1,25-dihydroxyvitamin D3-induced hypercalcaemia in a rat model and calcium release in vitro.
S M, Cheer, S, Noble
openaire +2 more sources

Zoledronic Acid Substantially Improves Bone Microarchitecture and Biomechanical Properties After Rotator Cuff Repair in a Rodent Chronic Defect Model

American Journal of Sports Medicine, 2020
Background: Bone mineral density at the humeral head is reduced in patients with chronic rotator cuff tears. Bone loss in the humeral head is associated with repair failure after rotator cuff reconstruction. Bisphosphonates (eg, zoledronic acid) increase
J. Schanda +11 more
semanticscholar +1 more source

Differences between zoledronic acid and denosumab for breast cancer treatment

Journal of Bone and Mineral Metabolism, 2023
Takashi Ishikawa
semanticscholar +1 more source

Zoledronic-acid